Home > Insider Trading > Filing (0001214659-20-004966)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1581280	Twist Bioscience Corp	TWST	Biological Products, (No Disgnostic Substances) (2836)	462058888

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1755970	John Patrick Finn	C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-05-20	3,508	$39.56	36,698	No	4	S	Direct
Common Stock	Disposition	2020-05-20	599	$40.21	36,099	No	4	S	Direct
Common Stock	Disposition	2020-05-20	100	$41.07	35,999	No	4	S	Direct
Common Stock	Disposition	2020-05-20	675	$39.76	35,324	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	F	Direct

Footnotes

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Represents the weighted average sales price per share. The shares sold at prices ranging from $38.96 to $39.89 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Represents the weighted average sales price per share. The shares sold at prices ranging from $40.04 to $40.65 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).